Educational Opportunities

The overall goal of IDEA (Innovating Decisions and Empowering Action in Diabetes Management) is to improve understanding of continuous glucose monitoring, report interpretations, and the use of this information to optimize therapeutic management leading to practice transformation and increased shared decision-making. Substantial evidence exists to support the safety and efficacy of CGM in adult and pediatric populations. Though challenges to adoption and use remain, newer generations of CGM with improved accuracy, factory calibration, and fingerstick replacement are decreasing burdens and improving efficacy. Guidelines for CGM use are progressing to recommend its use across the spectrum of people with diabetes.

The IDEA Project is a major educational initiative that will change the way CGM data is interpreted and used in diabetes care by health care professionals and by patients with diabetes.

IDEA 2.0 is a collection of 3 instructional modules and 10 interactive cases newly created for 2020. Also included is the Train-the-Trainer 60-minute webinar that describes the history of the IDEA project and the experts involved, identifies appropriate areas for its use within training curriculums, highlights IDEA content and cases, and articulates opportunities and next steps for modifying training curriculums with IDEA content.

Target Audience

This education is intended for endocrine specialists including endocrinologists, advanced practice professionals (nurse practitioners and physician assistants), dietitians, nurses, diabetes care and education specialists, and primary care providers (MDs, PAs, nurses) who care for patients with diabetes.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

• Identify current guidelines for utilization of CGM in the care of patients with diabetes
• Compare and contrast current CGM guideline recommendations
• Anticipate common questions from patients and clinicians related to CGM
• Discuss current and emerging advances in the use of CGM

Accreditation Statement

The American College of Endocrinology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Endocrinology designates this enduring activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

Successful completion of this CME activity enables the participant to earn up to 4 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points. 

Your participation information will be shared with the ACCME, which will in turn report your points to ABIM. Successful completion of a course examination is required to earn ABIM MOC points.

Collaborative Organizations:

• American Association of Clinical Endocrinology (AACE)
• Association of Diabetes Care & Education Specialists (ADCES)
• American College of Clinical Pharmacy (ACCP)
• American Society of Endocrine Physician Assistants (ASEPA)
• International Diabetes Center (IDC)
• American Academy of Physician Assistants (AAPA)
• Diabetes Patient Advocacy Coalition (DPAC)
• T1D Exchange
• The diaTribe Foundation
• The France Foundation (TFF)

Commercial Support

This activity is supported by educational grants from:

• Abbott Diabetes Care
• AstraZeneca
• Lilly USA, LLC
• Medtronic, Inc.
• Novo Nordisk Inc. 

**Faculty and preparer financial disclosures can be found within the online modules**

Don't miss out on the other part of our IDEA series — check out IDEA 1.0!